Manjari Singh, PhD, is currently working as an Assistant Professor in the Department of Pharmaceutical Sciences, Assam Central University, Silchar, India. She received her PhD degree from Babasaheb Bhimrao Ambedkar University, Lucknow, India. During the doctoral study, she has identified some novel prolyl-hydroxylase activators as potent breast cancer therapeutics. Her research area is focused on the regulation of hypoxia in the tumor microenvironment, in silico-based drug discovery, and in-vitro/in vivo disease models in cancer. Dr. Singh is a member of multiple editor/reviewer boards of different reputed journals and is a recipient of the various research grant. She has published 37 journal papers (authored/co-authored), four book chapters to date, and also been involved in pharmacology teaching to the graduate student.

• PART I: CHEMISTRY OF BIOACTIVE LIPIDS 1. Ceramide: A Sphingolipidic Weapon Against Cancer 2. Lipoxins: Emerging Players in the Resolution of Cancer 3. Role of Resolvins in Treatment of Cancer as a Bioactive Lipid 4. Sphingosine-1-Phosphate: An Important Target to Fight Against Cancer PART II: FORMULATION BASED ON BIOACTIVE LIPIDS 5. Bioactive Lipids for the Treatment of Cancer 6. Role of Exosomes as Natural Conveyors of Bioactive Lipids in Cancer PART III: MECHANISM OF BIOACTIVE LIPIDS 7. Identification of Bioactive Lipid Drug Targets by Computational Techniques 8. Metabolism of Lipids in Malignant Solid Tumors under Hypoxia and Drug Targets 9. Novel Targeting Therapy for Colorectal Cancer with Special Emphasis on KRAS and PI3K Pathway 10. Role of Lipid-Soluble Bioactive Substance from Avocado for Inhibition of Prostate and Other Cancers 11. Role of Lipopolysaccharide in the Pathogenesis of Cancer 12. Role of Lysophosphatidic Acid on Cancer 13. Role of Omega-3 Polyunsaturated Fatty Acids-Derived Lipid Metabolites on Cancer Hacks

Manjari Singh, PhD, is currently working as an Assistant Professor in the Department of Pharmaceutical Sciences, Assam Central University, Silchar, India. She received her PhD degree from Babasaheb Bhimrao Ambedkar University, Lucknow, India. During the doctoral study, she has identified some novel prolyl-hydroxylase activators as potent breast cancer therapeutics. Her research area is focused on the regulation of hypoxia in the tumor microenvironment, in silico-based drug discovery, and in-vitro/in vivo disease models in cancer. Dr. Singh is a member of multiple editor/reviewer boards of different reputed journals and is a recipient of the various research grant. She has published 37 journal papers (authored/co-authored), four book chapters to date, and also been involved in pharmacology teaching to the graduate student.

• PART I: CHEMISTRY OF BIOACTIVE LIPIDS 1. Ceramide: A Sphingolipidic Weapon Against Cancer 2. Lipoxins: Emerging Players in the Resolution of Cancer 3. Role of Resolvins in Treatment of Cancer as a Bioactive Lipid 4. Sphingosine-1-Phosphate: An Important Target to Fight Against Cancer PART II: FORMULATION BASED ON BIOACTIVE LIPIDS 5. Bioactive Lipids for the Treatment of Cancer 6. Role of Exosomes as Natural Conveyors of Bioactive Lipids in Cancer PART III: MECHANISM OF BIOACTIVE LIPIDS 7. Identification of Bioactive Lipid Drug Targets by Computational Techniques 8. Metabolism of Lipids in Malignant Solid Tumors under Hypoxia and Drug Targets 9. Novel Targeting Therapy for Colorectal Cancer with Special Emphasis on KRAS and PI3K Pathway 10. Role of Lipid-Soluble Bioactive Substance from Avocado for Inhibition of Prostate and Other Cancers 11. Role of Lipopolysaccharide in the Pathogenesis of Cancer 12. Role of Lysophosphatidic Acid on Cancer 13. Role of Omega-3 Polyunsaturated Fatty Acids-Derived Lipid Metabolites on Cancer Hacks

Manjari Singh, PhD, is currently working as an Assistant Professor in the Department of Pharmaceutical Sciences, Assam Central University, Silchar, India. She received her PhD degree from Babasaheb Bhimrao Ambedkar University, Lucknow, India. During the doctoral study, she has identified some novel prolyl-hydroxylase activators as potent breast cancer therapeutics. Her research area is focused on the regulation of hypoxia in the tumor microenvironment, in silico-based drug discovery, and in-vitro/in vivo disease models in cancer. Dr. Singh is a member of multiple editor/reviewer boards of different reputed journals and is a recipient of the various research grant. She has published 37 journal papers (authored/co-authored), four book chapters to date, and also been involved in pharmacology teaching to the graduate student.

• PART I: CHEMISTRY OF BIOACTIVE LIPIDS 1. Ceramide: A Sphingolipidic Weapon Against Cancer 2. Lipoxins: Emerging Players in the Resolution of Cancer 3. Role of Resolvins in Treatment of Cancer as a Bioactive Lipid 4. Sphingosine-1-Phosphate: An Important Target to Fight Against Cancer PART II: FORMULATION BASED ON BIOACTIVE LIPIDS 5. Bioactive Lipids for the Treatment of Cancer 6. Role of Exosomes as Natural Conveyors of Bioactive Lipids in Cancer PART III: MECHANISM OF BIOACTIVE LIPIDS 7. Identification of Bioactive Lipid Drug Targets by Computational Techniques 8. Metabolism of Lipids in Malignant Solid Tumors under Hypoxia and Drug Targets 9. Novel Targeting Therapy for Colorectal Cancer with Special Emphasis on KRAS and PI3K Pathway 10. Role of Lipid-Soluble Bioactive Substance from Avocado for Inhibition of Prostate and Other Cancers 11. Role of Lipopolysaccharide in the Pathogenesis of Cancer 12. Role of Lysophosphatidic Acid on Cancer 13. Role of Omega-3 Polyunsaturated Fatty Acids-Derived Lipid Metabolites on Cancer Hacks